TP53 and neoplasm: Compared with TP53-WT, TP53-MT has stronger pre-existing anti-tumor immune effects in tumors, including interferon-γ enrichment, positive regulation of TNF secretion pathway and increased expression of some immunostimulating molecules (such as CXCL9 and CXCL10).